BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26981507)

  • 1. Recurrent Glioblastoma: Where we stand.
    Roy S; Lahiri D; Maji T; Biswas J
    South Asian J Cancer; 2015; 4(4):163-73. PubMed ID: 26981507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma multiforme: overview of current treatment and future perspectives.
    Anton K; Baehring JM; Mayer T
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):825-53. PubMed ID: 22794286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
    Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
    J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
    Chen J; Xu T
    Front Biosci (Landmark Ed); 2013 Jan; 18(2):676-84. PubMed ID: 23276952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience.
    Hasan S; Chen E; Lanciano R; Yang J; Hanlon A; Lamond J; Arrigo S; Ding W; Mikhail M; Ghaneie A; Brady L
    Front Oncol; 2015; 5():106. PubMed ID: 26029663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
    Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
    J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
    Tentori L; Ricci-Vitiani L; Muzi A; Ciccarone F; Pelacchi F; Calabrese R; Runci D; Pallini R; Caiafa P; Graziani G
    BMC Cancer; 2014 Mar; 14():151. PubMed ID: 24593254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
    Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
    Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond.
    Daisy Precilla S; Kuduvalli SS; Thirugnanasambandhar Sivasubramanian A
    Cell Biol Int; 2021 Jan; 45(1):18-53. PubMed ID: 33049091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
    Ene CI; Cimino PJ; Fine HA; Holland EC
    Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Radiosurgery for Recurrent Glioblastoma Multiforme: A Retrospective Multi-Institutional Experience.
    Lovo EE; Moreira A; Barahona KC; Ramirez J; Campos F; Tobar C; Caceros V; Sallabanda M; Sallabanda K
    Cureus; 2021 Oct; 13(10):e18480. PubMed ID: 34754642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts.
    Gupta SK; Mladek AC; Carlson BL; Boakye-Agyeman F; Bakken KK; Kizilbash SH; Schroeder MA; Reid J; Sarkaria JN
    Clin Cancer Res; 2014 Jul; 20(14):3730-41. PubMed ID: 24838527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Radiosurgery for Glioblastoma.
    Redmond KJ; Mehta M
    Cureus; 2015 Dec; 7(12):e413. PubMed ID: 26848407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study.
    Greenspoon JN; Sharieff W; Hirte H; Overholt A; Devillers R; Gunnarsson T; Whitton A
    Onco Targets Ther; 2014; 7():485-90. PubMed ID: 24711705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.